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Abstract
Background: Leishmania parasites undergo profound morphological and biochemical changes
while passing through their life cycle. Protein kinases have been shown to be involved in the
differentiation from the extracellular flagellated promastigotes to the intracellular "non-flagellated"
amastigotes and vice versa. Moreover, these enzymes are likely involved in the regulation of the
proliferation of the different life stages.
Results: Here, we characterize LmxMPK4, a mitogen-activated protein (MAP) kinase homologue
from Leishmania mexicana. The kinase reveals all sequence motifs for classification as a MAP kinase.
LmxMPK4 proved to be active as a recombinant protein. The kinase is expressed in promastigotes
and amastigotes. It was impossible to generate homozygous gene deletion mutants for LmxMPK4
in promastigotes. Moreover, amastigotes bearing only an episomal copy of the gene stably retained
LmxMPK4 over a prolonged period without antibiotic pressure in infected mice.
Conclusion: LmxMPK4 is essential for promastigotes and amastigotes of Leishmania. It shows
significant amino acid sequence divergence to mammalian MAP kinases. Thus, LmxMPK4 is a
promising new drug target.
Background
Protein kinases are key regulatory molecules in all eukary-
otic cells. Together with their antagonists the protein
phosphatases they form complex networks of mutually
activating and silencing molecules. Their activity affects
vital processes like differentiation, proliferation, motility,
stress response, and apoptosis [1]. Mitogen-activated pro-
tein (MAP) kinases are often the final kinases in signal
transduction cascades relaying signals augmented by envi-
ronmental stimuli via multiple steps of reversible phos-
phorylation from different receptors to effector proteins
which can ultimately lead to changes in protein expres-
sion profiles. In higher eukaryotes the core of the MAP
kinase signal transduction cascade is comprised of a MAP
kinase kinase kinase (MKKK), a MAP kinase kinase (MKK)
and a MAP kinase. Upon a stimulus the MKKK is activated
by phosphorylation. The active MKKK phosphorylates a
MAP kinase kinase (MKK) on serine and/or threonine res-
idues in its phosphorylation loop. MKKs are dual-specifi-
city kinases which are able to phosphorylate their
substrates, the MAP kinases, on a threonine and a tyrosine
residue of the conserved TXY motif of the phosphoryla-
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Alignment of LmxMPK4 from L. mexicana with various MAP kinase amino acid sequences Figure 1
Alignment of LmxMPK4 from L. mexicana with various MAP kinase amino acid sequences. LmxMPK4, Leishmania 
mexicana MAP kinase 4 (GenBank accession number AJ293282; [6]); Trypanosoma brucei MAP kinase, TbMAPK2 (GeneDB 
accession number Tb10.70.2070; [10]); Trypanosoma cruzi MAP kinase (GeneDB accession number Tc00.1047053511299.70); 
Chlamydomonas reinhardtii MAP kinase (GenBank accession number BAB18271); Dictyostelium discoideum ERK1 (GenBank acces-
sion number U11077; [13]); Homo sapiens ERK2 (GenBank accession number CAA77753; [14]). Roman numerals I to XI indi-
cate kinase subdomains. The kinase domain is located between the two inverted triangles (▼ ). Arrows (↓) mark the potential 
regulatory phosphorylation sites in the TXY motif at Thr190 and Tyr192, filled circles (● ) indicate conserved amino acid resi-
dues it is not clear what you mean by conserved aa residues, and open circles (❍ ) depict the residues of the phosphate anchor 
ribbon for ATP binding. The asterisks (*) show the residues of the P+1 specificity pocket. The open triangle (∆) marks the 
invariant lysine residue (K59), which is essential for the phosphate transfer reaction. The CD-domain is shaded in light grey. 
Dashes indicate gaps introduced to optimize the alignment; dots represent identical residues. The carboxy-terminal peptide 
used to generate antibodies is underlined. (50), the terminal 50 amino acid residues of the Dictyostelium kinase have been omit-
ted. Numbering corresponds to LmxMPK4.
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tion loop in order to cause maximal enzymatic activity.
Finally, activated MAP kinases can translocate into the
nucleus and phosphorylate transcription factors or phos-
phorylate cytosolic kinases or structural proteins. Genome
sequencing and analysis of Leishmania major and L. infan-
tum  revealed the presence of all members of the MAP
kinase signal transduction core module [2]. However, nei-
ther typical receptors that lead to the activation of MAP
kinase signal transduction pathways like receptor tyrosine
kinases and G-protein coupled receptors nor typical MAP
kinase substrates like transcription factors for RNA
polymerase II promoters have been found in the parasites.
It is not known yet how regulation of gene expression is
achieved in the parasites, but it is likely that the substrates
of MAP kinases are gene regulatory molecules, albeit not
transcription factors. It is generally assumed that regula-
tion occurs on post-transcriptional levels like the matura-
tion of the mRNA from a polycistronic precursor to a
capped and poly-adenylated mRNA in trans splicing, the
mRNA stability, the efficiency of translation or even the
protein stability.
Leishmania parasites have a digenetic life cycle with mam-
mals and sand flies as their hosts. While passing through
their life cycle the parasites alternate between proliferative
forms, the procyclic promastigotes and the amastigotes,
and forms arrested in the cell cycle, the highly infectious
metacyclic promastigotes. Protein kinases are likely
involved in the regulation of the proliferation of the dif-
ferent life stages and in the differentiation processes from
procyclic promastigotes to metacyclic forms, to amastig-
otes after transmission to a mammal and uptake by host
macrophages, and back to promastigotes once the amas-
tigotes reach the gut of a sand fly. Members of the MAP
kinase signalling pathways have been found to play
important roles in differentiation and proliferation of
Leishmania. LmxMKK a MAP kinase kinase homologue is
involved in the formation and maintenance of the flagel-
lum in the promastigote. A null mutant displayed flagella
reduced to maximally 1/5 of the length of the wild type
flagellum [3]. It is likely that this kinase is involved in the
outgrowth of a new flagellum prior to cell division in the
promastigotes and in the differentiation from the amastig-
ote displaying a short flagellum not protruding from the
flagellar pocket, an invagination of the plasma membrane
at the base of the flagellum, to the promastigote with a
flagellum which could even be longer than the body of the
cell. With LmxMPK9 a second kinase belonging to a MAP
kinase signalling pathway has been found which is
involved in the regulation of flagellar length. Here, null
mutant promastigotes showed elongated flagella as com-
pared to wild type cells, indicating that this kinase affects
the shortening of the flagellum [4]. LmxMPK1, the first
MAP kinase homologue described in L. mexicana, has
been found to be essential for the proliferation of the
amastigotes [5]. A deletion mutant was still able to infect
host cells, transform to the amastigote morphology, but
was unable to proliferate. As such, this kinase is an ideal
drug target and a specific inhibitor would be promising to
treat the disease.
Here, we characterize LmxMPK4, a MAP kinase homo-
logue from L. mexicana, which is essential for promastig-
otes and amastigotes, and consequently also has the
potential to be used as a drug target to treat Leishmaniasis.
Results
Molecular characterisation of LmxMPK4
We cloned and sequenced the gene for LmxMPK4, which
is a MAP kinase homologue of L. mexicana. The open read-
ing frame (orf) of LmxMPK4 is comprised of 1089 bp cod-
ing for a protein of 363 amino acids and a calculated
molecular mass of 41.5 kDa [6]. LmxMPK4 is highly con-
served in the different Leishmania species (L. panamensis
98.6%,  L. donovani 97.5%,  L. infantum 97.5%, and L.
major 98.9% amino acid identities) and has homologues
in other kinetoplastids, like Trypanosoma brucei (67.2%; E
Southern analysis of genomic DNA Figure 2
Southern analysis of genomic DNA. 1, PstI; 2, HincII; 3, 
HindIII; 4, Acc65I; 5, XbaI; 6, SpeI; 7, EcoRV; 8, ClaI; 9, NdeI; 
10, NcoI; 11, MluI; 12, MunI. Digested DNA (5 µg) was elec-
trophoresed on a 0.7% agarose gel, blotted onto nylon mem-
branes and probed with a DIG-labelled DNA probe 
corresponding to a fragment of the open reading frame (nt 
240 – nt 930). Numbers indicate the approximate size of 
DNA markers in kb.
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value of 5e-139) and T. cruzi (67.4%; E value of 2e-143), in
Chlamydomonas rheinhardtii (43.9%; E value of 6e-82), and
in  Dictyostelium discoideum (45.0%; E value of 1e-85).
Moreover, it shows weak homology to the human MAP
kinases ERK1 (42%; E value of 1e-70) and ERK2 (42%; E
value of 6e-71). LmxMPK4 contains the twelve kinase sub-
domains and amino acid residues known to be highly
conserved in MAP kinases (Fig. 1). The kinase domain
reaches from tyrosine 17 to phenylalanine 318 encom-
passing nearly the entire protein leaving only a sixteen res-
idue amino-terminal and a 45 residue carboxy-terminal
region. The latter region reveals a potential common
docking (CD) domain (DAAEE), a region enriched for
negatively charged residues involved in the binding of
interacting proteins [7]. Subdomain I contains the phos-
phate anchor ribbon for ATP binding with the consensus
(GXGXXG). A conserved lysine residue (K59), which is
involved in orienting ATP for proper phosphate transfer is
located in subdomain II. The TXY motif carrying a
glutamine in its centre in LmxMPK4, and the P+1 specifi-
city pocket, both hallmarks for MAP kinases are present in
subdomain VIII. Finally, a number of other conserved res-
idues are found in the different subdomains. Southern
blot analysis of genomic DNA from L. mexicana showed
that LmxMPK4 is a single copy gene in the haploid
genome (Fig. 2). PstI cuts within the DNA fragment used
as a probe and thus showed two hybridizing bands
whereas all other restriction endonucleases only revealed
a single band.
Immunoblot analysis
Using a polyclonal antiserum raised in rabbits against a
carboxy-terminal peptide of LmxMPK4, the protein could
be detected in a lysate of 4 × 107 wild type promastigotes
after lipid extraction, but was hardly detectable in the
same number of lesion-derived amastigotes (Fig. 3, lanes
1 and 2). However, we could detect it in in vitro differenti-
ated and cultivated amastigotes which had been under
amastigote growth conditions for ten passages. Even here
1 × 108 cells had to be extracted and loaded onto the gel
to generate a faint band indicating that the protein is
down-regulated in the amastigotes (Fig. 3A, lane 3). On
the other hand, we could easily overexpress LmxMPK4
from an episome in promastigotes leading to an at least
tenfold overexpression (Fig. 3A, lane 4). To demonstrate
differential loading of protein amounts the blot was
stripped and re-probed with an antiserum against myo-
inositol-1-phosphate synthase, a protein known to be
equally expressed in promastigotes and amastigotes [8].
Expression of recombinant LmxMPK4 and kinase assay
To generate an enzymatically inactive KM-mutant
LmxMPK4 was mutated changing lysine 59 to methio-
nine. Both, the wild type and the mutant protein, were
subcloned into pGEX-KG [9] and expressed as recom-
binant glutathione S-transferase fusion proteins in
Escherichia coli. Both proteins resulted in the same pattern
of bands after enrichment on glutathione-sepharose, sep-
aration on SDS-polyacrylamide gels and staining with
Coomassie brilliant blue. The main contaminating bands
were the glutathione S-transferase fusion partner (not
shown), a less abundant protein of a higher molecular
mass, and a second band just below the GSTLmxMPK4
fusion protein (Fig. 4A, lanes 1 and 2). The latter contam-
inations were also found while expressing unrelated MAP
kinases from L. mexicana in E. coli and therefore are likely
of bacterial origin (data not shown). In kinase assays we
could detect autophosphorylation of LmxMPK4, but not
of the KM-mutant (Fig. 4A, lanes 1' and 2') indicating that
the phosphorylation of LmxMPK4 is not due to a bacterial
kinase which might have been co-purified. However, the
kinase activity was relatively weak as films had to be
exposed for up to three days to obtain the results shown
in figure 4. Phosphorylation of myelin basic protein
(MBP) could be obtained with some preparations of
recombinant LmxMPK4, but not others (data not shown).
We usually perform kinase assays in the presence of 10
mM Mg2+ and 2 mM Mn2+ at 27°C. It turned out that
manganese on its own in a concentration of 10 mM
worked best in kinase assays for LmxMPK4 (Fig. 4B).
Immunoblot of LmxMPK4 from L. mexicana wild type and  episomal overexpressor Figure 3
Immunoblot of LmxMPK4 from L. mexicana wild type 
and episomal overexpressor. Lane 1, L. mexicana wild 
type promastigotes (4 × 107 cells); lane 2, amastigotes 
derived from mouse lesion (4 × 107 cells); lane 3, wild type in 
vitro differentiated amastigotes (1 × 108 cells); lane 4, promas-
tigotes of LmxMPK4 episomal overexpressor (1 × 107 cells). 
A, blot probed with antiserum against the carboxy-terminal 
peptide of LmxMPK4; B, the blot was stripped and re-probed 
with a polyclonal antiserum against myo-inositol-1-phosphate 
synthase. The molecular masses of standard proteins are 
indicated in kilodaltons.
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Finally, a pH between 6.0 and 7.0 showed highest auto-
phosphorylation activity in the assay (Fig. 4C).
Deletion analysis of LmxMPK4
To investigate the function of LmxMPK4 in Leishmania
parasites we attempted to obtain homozygous deletion
mutants. In order to delete both alleles of the single copy
gene we generated constructs comprised of the 5'- and 3'-
untranslated regions (UTRs) of LmxMPK4  flanking the
hygromycin B phosphotransferase gene or the gene of the
phleomycin binding protein. Following first rounds of
homologous recombination we obtained single-allele
deletion mutants for all constructs (data not shown). All
our attempts to generate a null mutant for LmxMPK4
resulted in clones carrying the resistance marker genes in
the expected genomic context, however, they all retained
an extra copy of LmxMPK4 (data not shown). This result
seemed to be indicative for a gene which is required for
the promastigote life stage of L. mexicana. Therefore, we
decided to first add an episomal copy of the LmxMPK4
wild type gene into the promastigotes using the plasmid
pXPACLmxMPK4. The presence of the plasmid and the
degree of expression of the MAP kinase was checked by
Southern and immunoblot analyses (data not shown; Fig.
2, lane 4). Next we repeated our deletion strategy, this
time leading to a successful replacement of the genomic
alleles of LmxMPK4 in one clone (Fig. 5, lane 5), whereas
most of the recombinant parasites retained a genomic
allele of LmxMPK4 despite the presence of the gene on the
episome (an example is shown in Fig. 5, lane 4). The
resulting genomic null mutant parasites showed no obvi-
ous phenotype compared to the wild type promastigotes.
We used this cell line to infect female Balb/c mice and
monitored lesion development for more than 1.5 years.
All mice injected showed lesion development (data not
shown). Towards the end of the experiment we either sac-
rificed the mice and isolated the lesion-derived amastig-
otes for transformation to promastigotes, or took aspirates
of the lesion for polymerase chain reaction (PCR) analysis
to assess the absence or presence of the plasmid carrying
Recombinant expression of LmxMPK4 and kinase assay Figure 4
Recombinant expression of LmxMPK4 and kinase assay. Left panels, Coomassie-stained gels; right panels, autoradio-
graphs. A, recombinant GST-fusion proteins after kinase assay. Lanes 1 and 1', wild type LmxMPK4; lane 2 and 2', KM-mutant 
of LmxMPK4. B, kinase assay of GST-LmxMPK4 at different concentrations of Mg2+ and Mn2+. Lanes 1 and 1', 50 mM Mg2+; 
lanes 2 and 2', 10 mM Mg2+; lanes 3 and 3', 5 mM Mg2+; lanes 4 and 4', 10 mM Mg2+ and 2 mM Mn2+; lanes 5 and 5', 10 mM Mn2+; 
lanes 6 and 6', 2 mM Mn2+; lanes 7 and 7', 1 mM Mn2+. C, kinase assay of GST-LmxMPK4 at varying pH. Lanes 1 and 1', pH5.5; 
lanes 2 and 2', pH6.0; lanes 3 and 3', pH6.5; lanes 4 and 4', pH7.0; lanes 5 and 5', pH7.2; lanes 6 and 6', pH7.5; lanes 7 and 7', 
pH8.0; lanes 8 and 8', pH 8.5. Molecular masses of standard proteins are indicated in kilodalton.
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LmxMPK4. PCR on the total population of freshly differ-
entiated promastigotes proved the presence of LmxMPK4
in the population of cells. Re-isolation of plasmids from
freshly differentiated promastigotes and restriction analy-
sis confirmed the identity of the plasmid (data not
shown). To evaluate the presence of plasmids in amastig-
otes we isolated parasites by taking lesion aspirates. As a
control wild type amastigotes were isolated and treated
like the mutant amastigotes. The amastigotes were liber-
ated from their host cells by shear forces also disrupting
aggregates of amastigotes leading to a suspension of single
cells. The DNA of the cells was stained using SYTO16 (Inv-
itrogen, Heidelberg, Germany) followed by sorting of the
parasites into 96-well plates. A duplex PCR was performed
using a pair of oligonucleotide primers specific for the sin-
gle-copy gene LmxMPK9, which generates a 254 bp DNA
fragment, and a second pair of oligonucleotides specific to
detect the presence of LmxMPK4 by a 420 bp DNA frag-
ment. In a series of PCRs using different numbers of
sorted wild type amastigotes it turned out that at least ten
amastigotes per well had to be used to give reliable results
in the subsequent PCR. Only one reaction out of 44 failed
to show the control fragment for LmxMPK9 in the mutant.
This rare event of no amplification was not found for
LmxMPK9 in the wild type but was observed for LmxMPK4
in both wild type and mutant amastigotes indicating that
it is indeed a PCR failure and the plasmid is definitely
present in all cells. Looking at freshly differentiated pro-
mastigotes we obtained a significantly different picture. As
promastigotes could be purified much easier we suc-
ceeded to perform the duplex PCR on the single cell level
with high efficiency. Again a failure of the PCR could be
observed, as in 5% of all wells (4/77) the control fragment
was not amplified. The percentage of wells lacking the
LmxMPK4 fragment was 27% (21/77). This higher per-
centage is indicative for the presence of single cells lacking
the plasmid and thus the gene. As this gives no clue about
the ability of those promastigotes having lost the plasmid
to proliferate, we cloned the cells by serial dilution and
analysed the populations arising from single cells using
the duplex PCR. All 66 clones obtained still retained the
plasmid. Therefore, LmxMPK4 is essential for promastig-
otes and amastigotes.
Discussion
LmxMPK4 has been found to be a MAP kinase homologue
from L. mexicana by amino acid sequence comparison and
an active protein kinase by proving the activity of the
recombinant GST-fusion protein in in vitro kinase assays.
The protein was hardly detectable in amastigotes by
immunoblot analysis, however, the fact that amastigotes
lacking the genomic copies of LmxMPK4 retained a plas-
mid carrying the gene without any antibiotic selection
imposed on the cells while in the mouse for more than 1.5
years strongly suggests that the protein is expressed and
essential for this life stage. Moreover, all attempts to gen-
erate homozygous deletion mutants in the promastigotes
failed and constantly ended in parasites showing accurate
replacement of both alleles of LmxMPK4, but an addi-
tional copy of the gene which might reflect a chromo-
somal duplication. Thus, LmxMPK4 is required in the
insect stage promastigotes as well. This is contrary to
TbMAPK2, the T. brucei homologue of LmxMPK4, which
could be deleted in the mammalian stage bloodstream
form trypanosomes without a detectable phenotype [10].
However, differentiation of the null mutant to procyclic
trypanosomes by temperature shift from 37°C to 27°C
and addition of cis-aconitate revealed delayed differentia-
tion kinetics and an arrest of the parasites in all phases of
the cell cycle. It is likely, that in T. brucei procyclic forms
cell cycle progression depends on a constitutive stimulus
through TbMAPK2 signalling. In Leishmania the impor-
tance of LmxMPK4 is even extended to the mammalian
stage of the parasite making this kinase a potential drug
target to treat Leishmaniasis.
Conclusion
LmxMPK4 is a mitogen-activated protein kinase homo-
logue from L. mexicana, that is highly conserved through-
out different Leishmania species and is essential for the
two main proliferating life stages, the promastigotes and
amastigotes, of the parasite. Moreover, it reveals signifi-
cant amino acid divergence compared to MAP kinases
from mammals showing highest homology to protein
kinases from kinetoplastids, low homology to human
Deletion analysis of LmxMPK4 Figure 5
Deletion analysis of LmxMPK4. Southern blot analysis of 
different clones with a probe corresponding to the 3'-UTR of 
LmxMPK4. 1, L. mexicana wild type; 2, episome 
pXPACLmxMPK4 + ∆LmxMPK4+/- Phleo; 3, episome 
pXPACLmxMPK4 + ∆LmxMPK4+/- Hyg; 4, episome 
pXPACLmxMPK4 + ∆LmxMPK4-/-/+ Phleo/Hyg; 5, episome 
pXPACLmxMPK4 + ∆LmxMPK4-/- Phleo/Hyg. Numbers indi-
cate the approximate size of DNA markers in kb.
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kinases and kinases from Chlamydomonas and Dictyostel-
ium. Therefore, it represents a suitable and promising drug
target to prevent the proliferation of the parasites and cure
the disease.
Methods
Parasites
Promastigotes of L. mexicana MNYC/BZ/62/M379 were
grown as described [11]. Female Balb/c mice were infected
into the left hind foot pad at the age of 6–8 weeks with 1
× 107 promastigote parasites in 30 µl PBS (137 mM NaCl,
2.7 mM KCl, 8 mM Na2HPO4, 1.4 mM KH2PO4). Infec-
tion experiments have been approved by the Veterinary
Authorities of the Freie and Hansestadt Hamburg and
were performed in accordance with section 8a paragraph
1 together with section 10a of the German Animal Protec-
tion Law as amended on May 25, 1998, with latest
amendment from August 6, 2002 (GZ.: G 21132/591-
00.33). Using a caliper gage, the course of infection was
followed by measuring lesion size relative to the unin-
fected right hind footpad at 4–5 weeks intervals. Amastig-
otes were isolated from lesions of Balb/c mice as described
[5]. For small scale amastigote preparation the lesion was
aspirated 2–3 times with a 23 G × 1 1/4" needle and a
syringe. The isolated tissue was transferred into 0.5 ml of
cold SYTO16-buffer (21 mM Hepes pH 7.5, 137 mM
NaCl, 5 mM KCl, 6 mM Glucose) and kept on ice. The tis-
sue was passed five times through a 30 G × 1/2" needle to
generate single cells. 850 µl of cold SYTO16-buffer, 150 µl
DMSO and 0.5 µl of 33 µM SYTO16 (Invitrogen) in
DMSO were added, the cells mixed and incubated for 30
minutes at room temperature in the dark. Afterwards the
cells were washed twice with SYTO16-buffer and were
finally resuspended in 1 ml SYTO16-buffer and stored at
4°C in the dark before sorting. For promastigote staining
1.1 × 108  cells were taken from a log-phase culture,
washed twice with 1 ml SYTO16-buffer, and processed as
described above.
Gene cloning, sequencing and analysis
Positive phage clones for LmxMPK4 were selected using
digoxigenin (DIG)-labelled probes [6], amplified and
DNA inserts cloned into pBSKII(+) using EcoRI (Strata-
gene, La Jolla, CA) yielding pBE25LmxMPK4. A 4514 bp
ClaI DNA fragment was liberated from pBE25LmxMPK4
and ligated into pBSKII(+) yielding pB2CLmxMPK4. Both
DNA strands were sequenced. Plasmid isolation, DNA
sequencing and analysis, DNA isolation and blotting, and
hybridizations were performed basically as described
before [12]. A probe encompassing nt 204 – nt 930 of the
orf of LmxMPK4 was DIG-labelled using the oligonucle-
otides 5'-TGCGGGAGATGGAGATAA-3' and 5'-CTTCG-
CAGTTAATCGTCTT-3' and the PCR DIG probe synthesis
kit as described by the manufacturer (Roche, Mannheim,
Germany). For labelling of the 2350 bp SphI/NruI DNA
fragment corresponding to the 3' untranslated region of
LmxMPK4  the fragment was isolated from
pB2CLmxMPK4 and labelled using the DIG DNA label-
ling kit (Roche). LmxMPK4 sequence data have been sub-
mitted to the DDBJ/EMBL/GenBank databases under the
accession number AJ293282.
LmxMPK4 deletion constructs
The Expand™ High Fidelity PCR or the Expand Long Tem-
plate PCR System (Roche) was used for all polymerase
chain reaction (PCR) applications. To generate the con-
struct for a genomic allele deletion mutant for LmxMPK4
the flanking regions were amplified by PCR from
pB2CLmxMPK4 cut with BglII using 5'-GCTGAGCCAT-
GGTTCTCTATGCCTCC-3' and 5'-TGAAAGCCTAG-
GAATCTGGTGCTCTC-3' (3 min 94°C, 10 × [20 sec 94°C,
30 sec 45°C, 7 min 68°C], 20 × [20 sec 94°C, 30 sec
45°C, 7 min + 20 sec/cycle 68°C], 7 min 68°C, 4°C). The
gel-purified PCR-fragment was trimmed at the ends using
NcoI and AvrII, and ligated to a BspHI/NheI fragment con-
taining either the phleomycin binding protein gene (BLE)
or the hygromycin B phosphotransferase gene (HYG) as
described before [12], yielding pB11C∆LmxMPK4phleo
and pB21C∆LmxMPK4hyg. Both constructs were cut with
ClaI and NruI, the DNA fragments for homologous
recombination were gel-purified and used for electropora-
tion in two consecutive rounds and recombinants selected
in medium containing 5 µg ml-1 bleocin and 20 µg ml-1
hygromycin B [4].
Episomal expression constructs for LmxMPK4
For episomal expression of LmxMPK4 the orf was ampli-
fied from pB2CLmxMPK4 using 5'-CCCGATATCAT-
GACTCAGCTCGTCCC-3' and 5'-
CCCGATATCTCGAGCCTATTCGTTCAATTGTG-3' (5 min
94°C, 20 × [30 sec 94°C, 30 sec 45°C, 1 min 72°C], 7
min 72°C, 4°C) introducing EcoRV,  BspHI, and XhoI
restriction sites, trimmed with EcoRV and ligated into
pBSKII(+) to yield pB6ELmxMPK4. Both DNA strands
were sequenced. The 1104 bp EcoRV fragment carrying
LmxMPK4 was liberated and cloned into pX63polPAC lin-
earised at its single EcoRV site [4]. Cells were transfected
with 20 µg of the plasmid constructs designated
pXPACLmxMPK4 as described above, and transformants
were selected in SDM-79 using 20 µM puromycin.
Expression constructs, mutagenesis and antibody 
production
The 1095 bp BspHI/XhoI DNA fragment was isolated from
pB6ELmxMPK4, ligated into pGEX-KG [9] cut with NcoI
and  XhoI, and the resulting construct was transformed
into E. coli XL1-blue. Expression and purification of the
glutathione-S-transferase fusion protein was performed as
described before [4]. To generate an enzymatically inac-
tive version of LmxMPK4 lysine 59 was replaced byKinetoplastid Biology and Disease 2005, 4:6 http://www.kinetoplastids.com/content/4/1/6
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methionine. The oligonucleotides 5'-GTT-
GTCGCGAGTCTTTGGTGATCTTCGTG-3' and 5'-
AGACTCGCGACAACCGCATGATAGCCACTCGCT-
CACC-3' introducing NruI sites and the desired mutation
were used in a PCR on pB6ELmxMPK4 (94°C, 5 min; 10
× [94°C, 30 s; 45°C, 30 s; 68°C, 3 min]; 10 × [94°C, 30
s; 55°C, 30 s; 68°C, 3 min + 20 s/cycle]; 68°C, 7 min;
4°C). The amplified fragment was gel-purified, trimmed
at the ends using NruI, circularised by self-ligation, and
transformed into E. coli. Successful mutagenesis was con-
firmed by sequencing. Finally, the mutated gene was
cloned into pGEX-KG as described above. A rabbit antise-
rum was produced against the peptide CEDLWRVVEAH-
SQLNE corresponding to the 15 carboxy-terminal amino
acids of LmxMPK4 (Eurogentec, Seraing, Belgium).
Immunoblotting
Cells were harvested by centrifugation and washed once
using PBS. The pellet was resuspended in chloroform/
methanol/ddH2O (1:2:0.8) in a concentration of 2 × 108
cells/ml and left at room temperature for 30 min. The
extracted cells were pelleted for 10 min at 15000 × g at
room temperature and the pellet dried under vacuum
(speed-vac). Then the pellet was resuspended in 100 µl 50
mM Tris/HCl pH 8.0, 20 µM leupeptin, 1 mM phenyl-
methylsulfonyl fluoride, 5 mM 1,10-phenanthroline, 10
mM MgCl2, 100 U/ml benzonase (Merck, Darmstadt, Ger-
many) and incubated at 37°C for 30 min. Dithiothreitol
(DTT) was added to a final concentration of 50 mM and
the probe adjusted to 1 × SDS sample buffer (0.4% SDS,
4% glycerol, 0.0002% bromphenol blue, 50 mM DTT,
12.5 mM Tris-HCl pH 6.8). Probes were boiled for 10
min, 20–40 µl subjected to SDS-polyacrylamide gel elec-
trophoresis (PAGE) and blotted to poly(vinylidenedifluo-
ride) (PVDF) membranes. Immunodetection was carried
out as described before [5] using the polyclonal rabbit
antiserum and goat-anti-rabbit secondary antibodies cou-
pled to peroxidase (Dianova, Hamburg, Germany) fol-
lowed by chemiluminescence using the ECL system
(Amersham Pharmacia Biotech, Freiburg, Germany).
Kinase assay
1 µg of the purified kinase was used in 50 µl kinase assay
solution (50 mM Tris pH 7.5, 0–50 mM MgCl2, 0–10 mM
MnCl2, 0.1 M NaCl, 5 µCi (γ-32P)-ATP, 1 mM ATP, 5 µg
myelin basic protein) and incubated at 27°C. The differ-
ent pH conditions tested were reached using 50 mM mor-
pholinoethane sulfonic acid for pH6.5 and below, 3-(N-
morpholino)propanesulfonic acid for pH7 and 7.2, and
50 mM Tris/HCl for pH 7.5 and higher. 12.5 µl 5 × SDS
sample buffer were added and the solution heated for 10
min at 95°C. 25 µl of the solution were separated on a
12% SDS-PAGE, stained with Coomassie brilliant blue,
destained, dried and exposed to X-ray films at -70°C.
Cell sorting and PCR analysis
Single promastigotes stained with SYTO16 were gated
with a forward scatter FSC-A < 80 and a side scatter SSC-A
< 80 and sorted into skirted 96-well PCR plates (Sarstedt,
Nuembrecht, Germany) using a FACSAria (Becton & Dick-
inson, Franklin Lakes, NJ). For lesion-derived amastigotes
the smallest SYTO16-positive particles (FSC-A < 50, SSC-
A < 50) were sorted with ten cells per well. All PCR reac-
tions were performed in an Eppendorf Mastercycler ep
(Eppendorf, Hamburg, Germany). 25 µl of a mastermix
were added to each well that contained pro- or amastig-
otes. 24 µl of mastermix and 1 µl of genomic DNA (c =
0.24 µg/µl) of L. mexicana served as a positive control, as
a negative control 25 µl of mastermix were used. After
addition of the mastermix the plates were sealed with
adhesive foil (Sarstedt). 0.5 µl AccuPrime Taq  DNA
Polymerase (Invitrogen) were used in a volume of 25 µl
with 5 pmol of the respective oligonucleotide primers (10
min 94°C, 45 × [10 sec 94°C, 15 sec 60°C, 45 sec 68°C],
7 min 68°C, 4°C). For the amplification of the 254 bp
control DNA fragment derived from LmxMPK9  [6] we
used 5'-GTCAGCGTGCCAATGAAAT-3' and 5'-
CAAGCTCCGGTGCGCGGTA-3'. A 420 bp DNA fragment
corresponding to LmxMPK4 is amplified by 5'-TATGAT-
TCAAGCATTCCGCG-3' and 5'-CGGCCGATGCGGCTGA-
GAG-3'. The samples were analysed on 1.5% agarose gels.
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